Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: PBRT
Drug: AA
Radiation: PLNRT
Drug: LHRH agonist

Registration Number: NCT00567580

Lead Sponsor: Radiation Therapy Oncology Group

Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as flutamide, bicalutamide, and luteinizing hormone-releasing hormone agonist, may lessen the amount of androgens made by the body. It is not yet known which regimen of radiation therapy with or without androgen-deprivation therapy is more effective for prostate cancer.

PURPOSE: This randomized phase III trial is studying prostate radiation therapy to see how well it works compared with short-term androgen deprivation therapy given together with pelvic lymph node radiation therapy with or without prostate radiation therapy in treating patients with a rising PSA after surgery for prostate cancer.

Detailed Description: OBJECTIVES:

Primary

* To determine whether the addition of short-term androgen deprivation (STAD) to prostate bed radiotherapy (PBRT) improves freedom from progression (FFP) (i.e., maintenance of a prostate-specific antigen \[PSA\] less than the nadir+2 ng/mL, absence of clinical failure, and absence of death from any cause) for 5 years, over that of PBRT alone in men treated with salvage radiotherapy after radical prostatectomy.

* To determine whether STAD, pelvic lymph node radiotherapy (PLNRT), and PBRT improves FFP over that of STAD+PBRT and PBRT alone in men treated with salvage radiotherapy after radical prostatectomy.

Secondary

* To compare secondary biochemical failure, the development of hormone-refractory disease , distant metastasis, cause-specific mortality, and overall mortality at five years.

* To compare acute and late morbidity based on Common Toxicity Criteria for Adverse Effects (CTCAE), v. 3.0.

* To measure the expression of cell kinetic, apoptotic pathway, and angiogenesis-related genes in archival diagnostic tissue to better define the risk of FFP, distant failure, cause-specific mortality, and overall mortality after salvage radiotherapy for prostate cancer, independently of conventional clinical parameters now used.

* To quantify blood product-based proteomic and genomic (single nucleotide polymorphisms) patterns and urine-based genomic patterns before and at different times after treatment to better define the risk of FFP, distant failure, cause-specific mortality, and overall mortality after salvage radiotherapy for prostate cancer, independently of conventional clinical parameters now used.

* To assess the degree, duration, and significant differences of disease-specific health-related quality of life (HRQOL) decrements among treatment arms.

* To assess whether mood is improved and depression is decreased with the more aggressive therapy if it improves FFP.

* To collect paraffin-embedded tissue blocks, serum, plasma, urine, and buffy coat cells for future translational research analyses.

Tertiary

* To assess whether an incremental gain in FFP and survival with more aggressive therapy outweighs decrements in the primary generic domains of HRQOL (i.e., mobility, self care, usual activities, pain/discomfort, and anxiety/depression).

* To evaluate the cost-utility of the treatment arm demonstrating the most significant benefit (in terms of the primary outcome) in comparison with other widely accepted cancer and non-cancer therapies.

* To assess associations between serum levels of beta-amyloid and measures of cognition and mood and depression.

* An exploratory aim is to assess the relationship(s) between the American Urological Association Symptom Index (AUA SI) and urinary morbidity using the CTCAE v. 3.0 grading system.

OUTLINE: Patients are stratified according to seminal vesicle involvement (yes vs no), prostatectomy Gleason score (≤ 7 vs 8-9), pre-radiotherapy PSA (≥ 0.1 and ≤ 1.0 ng/mL vs \> 1.0 and \< 2.0 ng/mL), and pathology stage (pT2 and margin negative vs all others). Patients are randomized to 1 of 3 treatment arms.

Follow-up occurs 3, 6, and 12 months after the completion of radiation therapy, then every 6 months for 6 years, and then annually thereafter.

Recruitment & Eligibility

Status: ACTIVE_NOT_RECRUITING

Sex: Male

Target Recruitment: 1792

Inclusion Criteria

Adenocarcinoma of the prostate treated primarily with radical prostatectomy, pathologically proven to be lymph node negative by pelvic lymphadenectomy (N0) or lymph node status pathologically unknown (undissected pelvic lymph nodes [Nx]), i.e. lymph node dissection is not required;

• Any type of radical prostatectomy will be permitted, including retropubic, perineal, laparoscopic or robotically assisted. There is no time limit for the date of radical prostatectomy.
A post-radical prostatectomy entry prostate-specific antigen (PSA) of ≥ 0.1 and < 2.0 ng/mL at least 6 weeks (45 days) after prostatectomy and within 30 days of registration;
One of the following pathologic classifications:
- T3N0/Nx disease with or without a positive prostatectomy surgical margin; or
- T2N0/Nx disease with or without a positive prostatectomy surgical margin;
Prostatectomy Gleason score of 9 or less;
Zubrod Performance Status of 0-1;
Age ≥ 18;
No distant metastases, based upon the following minimum diagnostic workup:
- History/physical examination (including digital rectal exam) within 8 weeks (60 days) prior to registration;
- A computerized tomography (CT) scan of the pelvis (with contrast if renal function is acceptable; a noncontrast CT is permitted if the patient is not a candidate for contrast) or magnetic resonance imaging (MRI) of the pelvis within 120 days prior to registration;
- Bone scan within 120 days prior to registration; if the bone scan is suspicious, a plain x-ray and/or MRI must be obtained to rule out metastasis.
Adequate bone marrow function, within 90 days prior to registration, defined as follows:
- Platelets ≥ 100,000 cells/mm^3 based upon compete blood count (CBC);
- Hemoglobin ≥ 10.0 g/dl based upon CBC (Note: The use of transfusion or other intervention to achieve Hgb ≥ 10.0 g/dl is recommended).
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 2 x the upper limit of normal within 90 days prior to registration;
Serum total testosterone must be ≥ 40% of the lower limit of normal (LLN) of the assay used (testosterone ÷ LLN must be ≥ 0.40) within 90 days prior to registration (Note: Patients who have had a unilateral orchiectomy are eligible as long as this requirement is met);
Patients must sign a study-specific informed consent prior to study entry.

Exclusion Criteria

A palpable prostatic fossa abnormality/mass suggestive of recurrence, unless shown by biopsy under ultrasound guidance not to contain cancer;
N1 patients are ineligible, as are those with pelvic lymph node enlargement ≥ 1.5 cm in greatest dimension by CT scan or MRI of the pelvis, unless the enlarged lymph node is sampled and is negative;
Androgen deprivation therapy started prior to prostatectomy for > 6 months (180 days) duration. Note: The use of finasteride or dutasteride (±tamsulosin) for longer periods prior to prostatectomy is acceptable;
Androgen deprivation therapy started after prostatectomy and prior to registration (Note: The use of finasteride or dutasteride (±tamsulosin) after prostatectomy is not acceptable - must be stopped within 3 months after prostatectomy. Androgen deprivation therapy must be stopped within 3 months after prostatectomy);
Neoadjuvant chemotherapy before or after prostatectomy;
Prior chemotherapy for any other disease site if given within 5 years prior to registration;
Prior cryosurgery or brachytherapy of the prostate; prostatectomy should be the primary treatment and not a salvage procedure;
Prior pelvic radiotherapy;
Prior invasive malignancy (except non-melanomatous skin cancer) or superficial bladder cancer unless disease free for a minimum of 5 years [for example, carcinoma in situ of the oral cavity is permissible];
Severe, active co-morbidity, defined as follows:
- History of inflammatory bowel disease;
- History of hepatitis B or C; Blood tests are not required to determine if the patient has had hepatitis B or C, unless the patient reports a history of hepatitis.
- Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months;
- Transmural myocardial infarction within the last 6 months;
- Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration;
- Chronic Obstructive Pulmonary Disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration;
- Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; AST or ALT are required; note, however, that laboratory tests for coagulation parameters are not required for entry into this protocol.
- Acquired Immune Deficiency Syndrome (AIDS) based upon current Centers for Disease Control and Prevention (CDC) definition; Note, however, that human immunodeficiency viruses (HIV) testing is not required for entry into this protocol. The need to exclude patients with acquired immunodeficiency syndrome (AIDS) from this protocol is necessary because the treatments involved in this protocol may result in increased toxicity and immunosuppression.
Prior allergic reaction to the study drug(s) involved in this protocol.

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PBRT Alone	PBRT	Prostate bed radiotherapy (PBRT) begins within 6 weeks (+/- 2 weeks) after registration.
PBRT + STAD	PBRT	Prostate bed radiotherapy (PBRT) and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before radiotherapy (RT), and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PBRT + STAD	AA	Prostate bed radiotherapy (PBRT) and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before radiotherapy (RT), and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PBRT + STAD	LHRH agonist	Prostate bed radiotherapy (PBRT) and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before radiotherapy (RT), and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PLNRT + PBRT + STADT	PBRT	Pelvic lymph node radiotherapy (PLNRT), prostate bed radiotherapy (PBRT), and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before RT, and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PLNRT + PBRT + STADT	PLNRT	Pelvic lymph node radiotherapy (PLNRT), prostate bed radiotherapy (PBRT), and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before RT, and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PLNRT + PBRT + STADT	AA	Pelvic lymph node radiotherapy (PLNRT), prostate bed radiotherapy (PBRT), and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before RT, and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).
PLNRT + PBRT + STADT	LHRH agonist	Pelvic lymph node radiotherapy (PLNRT), prostate bed radiotherapy (PBRT), and short term androgen deprivation therapy (STAD) consisting of antiandrogen (AA) and luteinizing hormone-releasing hormone (LHRH) agonist therapy begins within 6 weeks (+/- 2 weeks) after registration. STAD starts first, 2 months (+/- 2 weeks) before RT, and lasts for 4-6 months. LHRH can last 4-6 months. AA starts at the same time as LHRH (or up to 2 weeks prior ), lasts approximately 4 months, and should end on the last day of RT (+/- 2 weeks).

Primary Outcome Measures

Name	Time	Method
Percentage of Participants Free From Progression (FFP) at 5 Years	From randomization to five years.	Progression is defined as the first occurrence of the following events: biochemical failure by the Phoenix definition (prostate-specific antigen \[PSA\] ≥ 2 ng/ml over the nadir PSA), clinical failure (local, regional or distant), or death from any cause. The initiation of second salvage therapy before progression was a protocol violation and resulted in censoring. Progression time is defined as time from randomization to the date of progression, second salvage therapy (censored), or last known follow-up (censored). Freedom from progression rates are estimated using the Kaplan-Meier method. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but results were reported early. See Limitations and Caveats section.

Secondary Outcome Measures

Name	Time	Method
Assessment and Comparison of Quality Adjusted Life Year (QALY) and Quality Adjusted FFP Year (QAFFPY)	From the 6th week of radiation therapy to 5 years post radiation therapy.
Evaluation and Comparison of the Cost-utility Using EuroQoL - 5 Dimensions (EQ-5D)	From the 6th week of radiation therapy to 5 years post radiation therapy.
Prognostic Value of Genomic and Proteomic Markers for the Primary and Secondary Clinical Endpoints	Date of randomization to timepoint of the respective primary or secondary endpoint.
Percentage of Participants With Secondary Biochemical Failure (Alternative Biochemical Failure)	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Secondary biochemical (failure) is defined as either of two occurrences: 1. For detectable post-baseline PSA values (≥ 0.1), the first occurrence of a PSA value that is both ≥ 0.4 and a second rise above nadir; 2.The start of second salvage therapy. Failure time is defined as time from randomization to the date of failure, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but results were reported early. See Limitations and Caveats section.
Percentage of Participants Free From Hormone-refractory Disease (Castrate-resistant Disease)	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Hormone-refractory disease (failure) is defined as three rises in PSA after the start of second salvage androgen deprivation therapy. Failure time is defined as time from randomization to the date of failure, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but the data monitoring committee decided to release results after the third interim analysis.
Percentage of Participants With Local Failure	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Local failure is defined as first occurrence of local clinical progression. Failure time is defined as time from randomization to the date of failure, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but the data monitoring committee decided to release results after the third interim analysis.
Percentage of Participants With Distant Metastasis	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Distant metastasis (failure) is defined as the occurrence of distant metastasis determined by imaging. Failure time is defined as time from randomization to the date of failure, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but the data monitoring committee decided to release results after the third interim analysis.
Percentage of Participants Who Died Due to Prostate Cancer (Cause-specific Mortality)	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Cause-specific mortality (failure) is defined as death due to prostate cancer or complications of protocol treatment (centrally reviewed), or death following disease progression (clinical or biochemical) in the absence of or after the initiation of any salvage therapy. \[Biochemical progression is indicated by any rise in PSA.\] Failure time is defined as time from randomization to the date of failure, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but the data monitoring committee decided to release results after the third interim analysis.
Percentage of Participants Alive (Overall Mortality)	From randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Survival time is defined as time from randomization to the date of death from any cause or last known follow-up (censored). Survival rates are estimated by the Kaplan-Meier method. Pairwise comparisons of the overall distributions of failure times are reported in statistical analysis section, with five-year rates reported here. The study was designed for the final analysis to occur after all participants had been on study for at least 5 years, but the data monitoring committee decided to release results after the third interim analysis.
Percentage of Participants Experiencing Grade 2+ and 3+ Adverse Events ≤ 90 Days of the Completion of Radiotherapy (RT)	From randomization to 90 days after completion of radiotherapy (approximately 7-8 weeks).	Common Terminology Criteria for Adverse Events (version 3.0) grades adverse event severity from 1=mild to 5=death. Summary data is provided in this outcome measure; see Adverse Events Module for specific adverse event data. Pairwise comparisons of Arm 2 vs Arm 1 and Arm 3 vs. Arm 2 are reported in the statistical analysis.
Comparison of Disease-specific Health Related Quality of Life (HRQOL) Change by the Expanded Prostate Cancer Index Composite (EPIC), Hopkins Verbal Learning Test Revised (HVLT-R), Trail Making Test A & B, and Controlled Oral Word Association Test (COWAT)	From the 6th week of radiation therapy to 5 years post radiation therapy.
Percentage of Participants Experiencing Late Grade 2+ and 3+ Adverse Events > 90 Days From the Completion of Radiotherapy (RT)	AE: from 91 days after completion of RT (approximately 7-8 weeks) to last follow-up. Vital status: from randomization to last follow-up. Maximum follow-up at time of analysis was 10.5 years.	Common Terminology Criteria for Adverse Events (version 3.0) grades adverse event severity from 1=mild to 5=death. Late adverse events (AE) are defined as occurring \> 90 days from the completion of RT. Failure time is defined as time from randomization to the date of first late grade 2 or grade 3 adverse event, death (competing risk), or last known follow-up (censored). Failure rates for data summary are estimated using the cumulative incidence method, with 5-year rates provided here. Pairwise comparisons of the distributions of failure times between Arm 2 and Arm 1 and between Arm 3 and Arm 2, reported in the statistical analysis section, use cause-specific hazard rates for which deaths are censored.
Assessment of Mood and Depression Change Using QOL Measured by the Hopkins Symptom Checklist (HSCL-25)	From the 6th week of radiation therapy to 5 years post radiation therapy.
Assessment of the Relationship(s) Between the American Urological Association Symptom Index (AUA SI) and Urinary Morbidity (Adverse Event Terms: Urinary Frequency/Urgency) Using the CTCAE v. 3.0 Grading System	From the 6th week of radiation therapy to 5 years post radiation therapy.

Trial Locations

Locations (460): Grant Medical Center Cancer Care
🇺🇸
Columbus, Ohio, United States
Mount Carmel Health - West Hospital
🇺🇸
Columbus, Ohio, United States
Doctors Hospital at Ohio Health
🇺🇸
Columbus, Ohio, United States
UPMC Cancer Center at Magee-Womens Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
UPMC Cancer Center at UPMC Presbyterian
🇺🇸
Pittsburgh, Pennsylvania, United States
UPMC Cancer Center at UPMC Passavant
🇺🇸
Pittsburgh, Pennsylvania, United States
UPMC Cancer Center - Upper St. Clair
🇺🇸
Pittsburgh, Pennsylvania, United States
Mount Sinai Hospital Medical Center
🇺🇸
Chicago, Illinois, United States
Case Comprehensive Cancer Center
🇺🇸
Cleveland, Ohio, United States
Cleveland Clinic Cancer Center at Fairview Hospital
🇺🇸
Cleveland, Ohio, United States
Massachusetts General Hospital
🇺🇸
Boston, Massachusetts, United States
Dana-Farber/Brigham and Women's Cancer Center
🇺🇸
Boston, Massachusetts, United States
Boston University Cancer Research Center
🇺🇸
Boston, Massachusetts, United States
Baptist-South Miami Regional Cancer Program
🇺🇸
Miami, Florida, United States
UCSF Helen Diller Family Comprehensive Cancer Center
🇺🇸
San Francisco, California, United States
California Pacific Medical Center - California Campus
🇺🇸
San Francisco, California, United States
Cancer Care Centers of South Texas - Northeast
🇺🇸
San Antonio, Texas, United States
Huntsman Cancer Institute at University of Utah
🇺🇸
Salt Lake City, Utah, United States
Arizona Oncology Services Foundation
🇺🇸
Phoenix, Arizona, United States
Josephine Ford Cancer Center at Henry Ford Hospital
🇺🇸
Detroit, Michigan, United States
Oklahoma University Cancer Institute
🇺🇸
Oklahoma City, Oklahoma, United States
East Bay Radiation Oncology Center
🇺🇸
Castro Valley, California, United States
Mercy Cancer Center at Mercy San Juan Medical Center
🇺🇸
Carmichael, California, United States
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
🇺🇸
Fairbanks, Alaska, United States
Peninsula Medical Center
🇺🇸
Burlingame, California, United States
Enloe Cancer Center at Enloe Medical Center
🇺🇸
Chico, California, United States
Radiation Oncology Centers - Cameron Park
🇺🇸
Cameron Park, California, United States
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
🇺🇸
Los Angeles, California, United States
USC/Norris Comprehensive Cancer Center and Hospital
🇺🇸
Los Angeles, California, United States
Contra Costa Regional Medical Center
🇺🇸
Martinez, California, United States
El Camino Hospital Cancer Center
🇺🇸
Mountain View, California, United States
Providence Holy Cross Cancer Center
🇺🇸
Mission Hills, California, United States
Memorial Medical Center
🇺🇸
Modesto, California, United States
Solano Radiation Oncology Center
🇺🇸
Vacaville, California, United States
Bay Area Breast Surgeons, Incorporated
🇺🇸
Oakland, California, United States
North Colorado Medical Center
🇺🇸
Greeley, Colorado, United States
Larry G Strieff MD Medical Corporation
🇺🇸
Oakland, California, United States
Pacific Cancer Institute - Maui
🇺🇸
Wailuku, Hawaii, United States
Tom K Lee, Incorporated
🇺🇸
Oakland, California, United States
Saint Helena Hospital
🇺🇸
Saint Helena, California, United States
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
🇺🇸
Boise, Idaho, United States
Creticos Cancer Center at Advocate Illinois Masonic Medical Center
🇺🇸
Chicago, Illinois, United States
Middlesex Hospital Cancer Center
🇺🇸
Middletown, Connecticut, United States
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
🇺🇸
Chicago, Illinois, United States
St. Mary - Corwin Regional Medical Center
🇺🇸
Pueblo, Colorado, United States
Swedish Medical Center
🇺🇸
Englewood, Colorado, United States
University of Chicago Cancer Research Center
🇺🇸
Chicago, Illinois, United States
Flagler Cancer Center
🇺🇸
Saint Augustine, Florida, United States
Integrated Community Oncology Network
🇺🇸
Jacksonville Beach, Florida, United States
Decatur Memorial Hospital Cancer Care Institute
🇺🇸
Decatur, Illinois, United States
Baptist Cancer Institute - Jacksonville
🇺🇸
Jacksonville, Florida, United States
Integrated Community Oncology Network - Orange Park
🇺🇸
Orange Park, Florida, United States
Northside Hospital Cancer Center
🇺🇸
Atlanta, Georgia, United States
Leonard C. Ferguson Cancer Center
🇺🇸
Freeport, Illinois, United States
Veterans Affairs Medical Center - Hines
🇺🇸
Hines, Illinois, United States
Cancer Institute at St. John's Hospital
🇺🇸
Springfield, Illinois, United States
Regional Cancer Center at Memorial Medical Center
🇺🇸
Springfield, Illinois, United States
Radiation Oncology Associates Southwest
🇺🇸
Fort Wayne, Indiana, United States
Parkview Regional Cancer Center at Parkview Health
🇺🇸
Fort Wayne, Indiana, United States
Center for Cancer Care at Goshen General Hospital
🇺🇸
Goshen, Indiana, United States
Howard Community Hospital
🇺🇸
Kokomo, Indiana, United States
Center for Cancer Therapy at LaPorte Hospital and Health Services
🇺🇸
La Porte, Indiana, United States
St. Luke's Regional Medical Center
🇺🇸
Sioux City, Iowa, United States
Memorial Hospital of South Bend
🇺🇸
South Bend, Indiana, United States
Cancer Center of Kansas, PA - Wichita
🇺🇸
Wichita, Kansas, United States
Mercy Medical Center - Sioux City
🇺🇸
Sioux City, Iowa, United States
Cancer Center of Kansas, PA - Dodge City
🇺🇸
Dodge City, Kansas, United States
Associates in Womens Health, PA - North Review
🇺🇸
Wichita, Kansas, United States
Genesys Hurley Cancer Institute
🇺🇸
Flint, Michigan, United States
Cancer Center of Kansas, PA - Medical Arts Tower
🇺🇸
Wichita, Kansas, United States
Wesley Medical Center
🇺🇸
Wichita, Kansas, United States
McLaren Cancer Institute
🇺🇸
Flint, Michigan, United States
Beth Israel Deaconess Medical Center
🇺🇸
Boston, Massachusetts, United States
CCOP - Wichita
🇺🇸
Wichita, Kansas, United States
Henry Ford Macomb Hospital
🇺🇸
Clinton Township, Michigan, United States
Cape Cod Hospital
🇺🇸
Hyannis, Massachusetts, United States
Hudner Oncology Center at Saint Anne's Hospital - Fall River
🇺🇸
Fall River, Massachusetts, United States
Greenebaum Cancer Center at University of Maryland Medical Center
🇺🇸
Baltimore, Maryland, United States
Via Christi Cancer Center at Via Christi Regional Medical Center
🇺🇸
Wichita, Kansas, United States
Oakwood Cancer Center at Oakwood Hospital and Medical Center
🇺🇸
Dearborn, Michigan, United States
Central Maryland Oncology Center
🇺🇸
Columbia, Maryland, United States
St. Agnes Hospital Cancer Center
🇺🇸
Baltimore, Maryland, United States
Lowell General Hospital
🇺🇸
Lowell, Massachusetts, United States
Hickman Cancer Center at Bixby Medical Center
🇺🇸
Adrian, Michigan, United States
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
🇺🇸
Minneapolis, Minnesota, United States
United Hospital
🇺🇸
Saint Paul, Minnesota, United States
St. Luke's Hospital Cancer Care Center
🇺🇸
Duluth, Minnesota, United States
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
🇺🇸
Saint Louis, Missouri, United States
CCOP - Metro-Minnesota
🇺🇸
Saint Louis Park, Minnesota, United States
Park Nicollet Cancer Center
🇺🇸
Saint Louis Park, Minnesota, United States
Regions Hospital Cancer Care Center
🇺🇸
Saint Paul, Minnesota, United States
Immanuel St. Joseph's
🇺🇸
Mankato, Minnesota, United States
Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters
🇺🇸
Saint Peters, Missouri, United States
Great Falls Clinic - Main Facility
🇺🇸
Great Falls, Montana, United States
Sands Cancer Center
🇺🇸
Canandaigua, New York, United States
Lipson Cancer and Blood Center at Rochester General Hospital
🇺🇸
Rochester, New York, United States
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
🇺🇸
Marlton, New Jersey, United States
New York Methodist Hospital
🇺🇸
Brooklyn, New York, United States
CCOP - Nevada Cancer Research Foundation
🇺🇸
Las Vegas, Nevada, United States
Valley Hospital - Ridgewood
🇺🇸
Ridgewood, New Jersey, United States
Somerset Medical Center
🇺🇸
Somerville, New Jersey, United States
Frederick R. and Betty M. Smith Cancer Treatment Center
🇺🇸
Sparta, New Jersey, United States
New York Oncology Hematology, PC at Albany Regional Cancer Care
🇺🇸
Albany, New York, United States
University of New Mexico Cancer Center - South
🇺🇸
Las Cruces, New Mexico, United States
Memorial Sloan-Kettering Cancer Center
🇺🇸
Commack, New York, United States
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
🇺🇸
Sleepy Hollow, New York, United States
Moses Cone Regional Cancer Center at Wesley Long Community Hospital
🇺🇸
Greensboro, North Carolina, United States
CarolinaEast Cancer Care
🇺🇸
New Bern, North Carolina, United States
Annie Penn Cancer Center
🇺🇸
Reidsville, North Carolina, United States
Rex Cancer Center at Rex Hospital
🇺🇸
Raleigh, North Carolina, United States
Zimmer Cancer Center at New Hanover Regional Medical Center
🇺🇸
Wilmington, North Carolina, United States
Coastal Carolina Radiation Oncology Center
🇺🇸
Wilmington, North Carolina, United States
South Atlantic Radiation Oncology, LLC
🇺🇸
Supply, North Carolina, United States
Altru Cancer Center at Altru Hospital
🇺🇸
Grand Forks, North Dakota, United States
McDowell Cancer Center at Akron General Medical Center
🇺🇸
Akron, Ohio, United States
Barberton Citizens Hospital
🇺🇸
Barberton, Ohio, United States
Aultman Cancer Center at Aultman Hospital
🇺🇸
Canton, Ohio, United States
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
🇺🇸
Columbus, Ohio, United States
CCOP - Columbus
🇺🇸
Columbus, Ohio, United States
Cleveland Clinic Taussig Cancer Center
🇺🇸
Cleveland, Ohio, United States
North Coast Cancer Care, Incorporated
🇺🇸
Sandusky, Ohio, United States
Cleveland Clinic Foundation - Strongsville
🇺🇸
Strongsville, Ohio, United States
Mercy Hospital of Tiffin
🇺🇸
Tiffin, Ohio, United States
Medical University of Ohio Cancer Center
🇺🇸
Toledo, Ohio, United States
Providence Cancer Center at PMCC
🇺🇸
Medford, Oregon, United States
Legacy Mount Hood Medical Center
🇺🇸
Gresham, Oregon, United States
Legacy Meridian Park Hospital
🇺🇸
Tualatin, Oregon, United States
UPMC Cancer Center at the John P. Murtha Pavilion
🇺🇸
Johnstown, Pennsylvania, United States
Dubs Cancer Center at Rogue Valley Medical Center
🇺🇸
Medford, Oregon, United States
Salem Hospital Regional Cancer Care Services
🇺🇸
Salem, Oregon, United States
Bryn Mawr Hospital
🇺🇸
Bryn Mawr, Pennsylvania, United States
St. Luke's Cancer Network at St. Luke's Hospital
🇺🇸
Bethlehem, Pennsylvania, United States
Rosenfeld Cancer Center at Abington Memorial Hospital
🇺🇸
Abington, Pennsylvania, United States
UPMC Cancer Center - Arnold Palmer Pavilion
🇺🇸
Greensburg, Pennsylvania, United States
Allegheny Cancer Center at Allegheny General Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
UPMC - Shadyside
🇺🇸
Pittsburgh, Pennsylvania, United States
Alle-Kiski Medical Center
🇺🇸
Natrona Heights, Pennsylvania, United States
St. Mary Regional Cancer Center
🇺🇸
Langhorne, Pennsylvania, United States
UPMC - Moon
🇺🇸
Moon, Pennsylvania, United States
UPMC Cancer Center - Natrona Heights
🇺🇸
Natrona Heights, Pennsylvania, United States
Intercommunity Cancer Center
🇺🇸
Monroeville, Pennsylvania, United States
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
🇺🇸
Philadelphia, Pennsylvania, United States
Washington Hospital Cancer Center
🇺🇸
Washington, Pennsylvania, United States
UPMC Cancer Center at UPMC St. Margaret
🇺🇸
Pittsburgh, Pennsylvania, United States
Cancer Centers of the Carolinas - Seneca
🇺🇸
Seneca, South Carolina, United States
Cancer Centers of the Carolinas - Spartanburg
🇺🇸
Spartanburg, South Carolina, United States
CCOP - Main Line Health
🇺🇸
Wynnewood, Pennsylvania, United States
Cancer Centers of the Carolinas - Eastside
🇺🇸
Greenville, South Carolina, United States
Cancer Centers of the Carolinas - Faris Road
🇺🇸
Greenville, South Carolina, United States
CCOP - Greenville
🇺🇸
Greenville, South Carolina, United States
Cancer Centers of the Carolinas - Greer Medical Oncology
🇺🇸
Greer, South Carolina, United States
Cancer Centers of the Carolinas - Greer Radiation Oncology
🇺🇸
Greer, South Carolina, United States
Memorial Hermann Hospital - Memorial City
🇺🇸
Houston, Texas, United States
Texas Oncology, PA at Lake Vista Cancer Center
🇺🇸
Lewisville, Texas, United States
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
🇺🇸
Ogden, Utah, United States
West Tennessee Cancer Center at Jackson-Madison County General Hospital
🇺🇸
Jackson, Tennessee, United States
University of Texas Medical Branch
🇺🇸
Galveston, Texas, United States
Tyler Cancer Center
🇺🇸
Tyler, Texas, United States
Utah Cancer Specialists at UCS Cancer Center
🇺🇸
Salt Lake City, Utah, United States
Dixie Regional Medical Center - East Campus
🇺🇸
Saint George, Utah, United States
LDS Hospital
🇺🇸
Salt Lake City, Utah, United States
Norris Cotton Cancer Center - North
🇺🇸
Saint Johnsbury, Vermont, United States
CCOP - Virginia Mason Research Center
🇺🇸
Seattle, Washington, United States
CCOP - Northwest
🇺🇸
Tacoma, Washington, United States
Bay Area Cancer Care Center at Bay Area Medical Center
🇺🇸
Marinette, Wisconsin, United States
Langlade Memorial Hospital
🇺🇸
Antigo, Wisconsin, United States
Beloit Memorial Hospital
🇺🇸
Beloit, Wisconsin, United States
Bellin Memorial Hospital
🇺🇸
Green Bay, Wisconsin, United States
St. Vincent Hospital Regional Cancer Center
🇺🇸
Green Bay, Wisconsin, United States
Columbia Saint Mary's Hospital - Ozaukee
🇺🇸
Mequon, Wisconsin, United States
Riverview UW Cancer Center at Riverview Hospital
🇺🇸
Wisconsin Rapids, Wisconsin, United States
Franciscan Skemp Healthcare - La Crosse Campus
🇺🇸
La Crosse, Wisconsin, United States
Waukesha Memorial Hospital Regional Cancer Center
🇺🇸
Waukesha, Wisconsin, United States
Aurora Medical Center
🇺🇸
Summit, Wisconsin, United States
Cancer Care Program at Thunder Bay Regional Health Sciences
🇨🇦
Thunder Bay, Ontario, Canada
Rocky Mountain Oncology
🇺🇸
Casper, Wyoming, United States
Saint John Regional Hospital
🇨🇦
Saint John, New Brunswick, Canada
Pamela Youde Nethersole Eastern Hospital
🇨🇳
Hong Kong, China
Hopital Notre-Dame du CHUM
🇨🇦
Montreal, Quebec, Canada
Rabin Medical Center - Beilinson Campus
🇮🇱
Petach Tikva, Israel
Tel-Aviv Sourasky Medical Center
🇮🇱
Tel Aviv, Israel
Allan Blair Cancer Centre at Pasqua Hospital
🇨🇦
Regina, Saskatchewan, Canada
UAB Comprehensive Cancer Center
🇺🇸
Birmingham, Alabama, United States
St. Anthony Central Hospital
🇺🇸
Denver, Colorado, United States
Presbyterian - St. Luke's Medical Center
🇺🇸
Denver, Colorado, United States
St. Joseph Hospital
🇺🇸
Denver, Colorado, United States
Legacy Good Samaritan Hospital & Comprehensive Cancer Center
🇺🇸
Portland, Oregon, United States
Mayo Clinic Cancer Center
🇺🇸
Rochester, Minnesota, United States
Tom Baker Cancer Centre - Calgary
🇨🇦
Calgary, Alberta, Canada
Maisonneuve-Rosemont Hospital
🇨🇦
Montreal, Quebec, Canada
CHUS-Hopital Fleurimont
🇨🇦
Sherbrooke, Quebec, Canada
Mercy and Unity Cancer Center at Unity Hospital
🇺🇸
Fridley, Minnesota, United States
HealthEast Cancer Care at St. John's Hospital
🇺🇸
Maplewood, Minnesota, United States
Hennepin County Medical Center - Minneapolis
🇺🇸
Minneapolis, Minnesota, United States
Minnesota Oncology - Maplewood
🇺🇸
Maplewood, Minnesota, United States
St. Francis Cancer Center at St. Francis Medical Center
🇺🇸
Shakopee, Minnesota, United States
Ridgeview Medical Center
🇺🇸
Waconia, Minnesota, United States
Minnesota Oncology - Woodbury
🇺🇸
Woodbury, Minnesota, United States
Cancer Center of Kansas, PA - Winfield
🇺🇸
Winfield, Kansas, United States
University Radiation Oncology at Parkridge Hospital
🇺🇸
Rochester, New York, United States
Veterans Affairs Medical Center - Long Beach
🇺🇸
Long Beach, California, United States
Auburn Radiation Oncology
🇺🇸
Auburn, California, United States
Sutter Health - Western Division Cancer Research Group
🇺🇸
Novato, California, United States
Radiation Oncology Center - Roseville
🇺🇸
Roseville, California, United States
Sentara Cancer Institute at Sentara Norfolk General Hospital
🇺🇸
Norfolk, Virginia, United States
Naval Medical Center - Portsmouth
🇺🇸
Portsmouth, Virginia, United States
Hurley Medical Center
🇺🇸
Flint, Michigan, United States
Bronson Methodist Hospital
🇺🇸
Kalamazoo, Michigan, United States
Van Elslander Cancer Center at St. John Hospital and Medical Center
🇺🇸
Grosse Pointe Woods, Michigan, United States
Door County Cancer Center at Door County Memorial Hospital
🇺🇸
Sturgeon Bay, Wisconsin, United States
Ingalls Cancer Care Center at Ingalls Memorial Hospital
🇺🇸
Harvey, Illinois, United States
Tulane Cancer Center Office of Clinical Research
🇺🇸
Alexandria, Louisiana, United States
Radiological Associates of Sacramento Medical Group, Incorporated
🇺🇸
Sacramento, California, United States
University of California Davis Cancer Center
🇺🇸
Sacramento, California, United States
Mercy General Hospital
🇺🇸
Sacramento, California, United States
Rocky Mountain Cancer Centers - Aurora
🇺🇸
Aurora, Colorado, United States
University of Colorado Cancer Center at UC Health Sciences Center
🇺🇸
Aurora, Colorado, United States
Saint Joseph Mercy Cancer Center
🇺🇸
Ann Arbor, Michigan, United States
CCOP - Michigan Cancer Research Consortium
🇺🇸
Ann Arbor, Michigan, United States
University of Michigan Comprehensive Cancer Center
🇺🇸
Ann Arbor, Michigan, United States
CCOP - Missouri Valley Cancer Consortium
🇺🇸
Omaha, Nebraska, United States
Methodist Estabrook Cancer Center
🇺🇸
Omaha, Nebraska, United States
Immanuel Medical Center
🇺🇸
Omaha, Nebraska, United States
Alegant Health Cancer Center at Bergan Mercy Medical Center
🇺🇸
Omaha, Nebraska, United States
Lakeside Hospital
🇺🇸
Omaha, Nebraska, United States
Creighton University Medical Center
🇺🇸
Omaha, Nebraska, United States
Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center
🇺🇸
Milwaukee, Wisconsin, United States
Medical College of Wisconsin Cancer Center
🇺🇸
Milwaukee, Wisconsin, United States
Veterans Affairs Medical Center - Milwaukee
🇺🇸
Milwaukee, Wisconsin, United States
Arizona Center for Cancer Care - Peoria
🇺🇸
Peoria, Arizona, United States
Arizona Oncology - Tucson
🇺🇸
Tucson, Arizona, United States
Valley Medical Oncology
🇺🇸
Fremont, California, United States
Valley Medical Oncology Consultants - Castro Valley
🇺🇸
Castro Valley, California, United States
Rebecca and John Moores UCSD Cancer Center
🇺🇸
La Jolla, California, United States
California Cancer Center - Woodward Park Office
🇺🇸
Fresno, California, United States
Washington Township Hospital
🇺🇸
Fremont, California, United States
Cancer Care Associates
🇺🇸
Fresno, California, United States
Alta Bates Summit Medical Center - Summit Campus
🇺🇸
Oakland, California, United States
CCOP - Bay Area Tumor Institute
🇺🇸
Oakland, California, United States
Feather River Hospital Cancer Center
🇺🇸
Paradise, California, United States
Aurora Presbyterian Hospital
🇺🇸
Aurora, Colorado, United States
Doctors Medical Center - San Pablo Campus
🇺🇸
San Pablo, California, United States
Sutter Solano Medical Center
🇺🇸
Vallejo, California, United States
Porter Adventist Hospital
🇺🇸
Denver, Colorado, United States
Boulder Community Hospital
🇺🇸
Boulder, Colorado, United States
North Suburban Medical Center
🇺🇸
Thornton, Colorado, United States
McKee Medical Center
🇺🇸
Loveland, Colorado, United States
Hope Cancer Care Center at Longmont United Hospital
🇺🇸
Longmont, Colorado, United States
William W. Backus Hospital
🇺🇸
Norwich, Connecticut, United States
Exempla Lutheran Medical Center
🇺🇸
Wheat Ridge, Colorado, United States
Washington Cancer Institute at Washington Hospital Center
🇺🇸
Washington, District of Columbia, United States
CCOP - Christiana Care Health Services
🇺🇸
Newark, Delaware, United States
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
🇺🇸
New Britain, Connecticut, United States
Integrated Community Oncology Network at Southside Cancer Center
🇺🇸
Jacksonville, Florida, United States
Baptist Medical Center South
🇺🇸
Jacksonville, Florida, United States
Florida Cancer Center - Palatka
🇺🇸
Palatka, Florida, United States
Veterans Affairs Medical Center - Tampa
🇺🇸
Tampa, Florida, United States
Emory Crawford Long Hospital
🇺🇸
Atlanta, Georgia, United States
Piedmont Hospital
🇺🇸
Atlanta, Georgia, United States
Winship Cancer Institute of Emory University
🇺🇸
Atlanta, Georgia, United States
John B. Amos Cancer Center
🇺🇸
Columbus, Georgia, United States
Northside Hospital-Forsyth
🇺🇸
Cumming, Georgia, United States
Piedmont Fayette Hospital
🇺🇸
Fayetteville, Georgia, United States
Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
🇺🇸
Savannah, Georgia, United States
Kapiolani Medical Center at Pali Momi
🇺🇸
'Aiea, Hawaii, United States
Cardinal Bernardin Cancer Center at Loyola University Medical Center
🇺🇸
Maywood, Illinois, United States
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
🇺🇸
Moline, Illinois, United States
Elkhart General Hospital
🇺🇸
Elkhart, Indiana, United States
Saint Joseph Regional Medical Center
🇺🇸
Mishawaka, Indiana, United States
CCOP - Northern Indiana CR Consortium
🇺🇸
South Bend, Indiana, United States
Siouxland Hematology-Oncology Associates, LLP
🇺🇸
Sioux City, Iowa, United States
Cancer Center of Kansas, PA - Wellington
🇺🇸
Wellington, Kansas, United States
Lawrence Memorial Hospital
🇺🇸
Lawrence, Kansas, United States
Mary Bird Perkins Cancer Center - Baton Rouge
🇺🇸
Baton Rouge, Louisiana, United States
Greater Baltimore Medical Center Cancer Center
🇺🇸
Baltimore, Maryland, United States
Tate Cancer Center at Baltimore Washington Medical Center
🇺🇸
Glen Burnie, Maryland, United States
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
🇺🇸
Boston, Massachusetts, United States
Holy Cross Hospital
🇺🇸
Silver Spring, Maryland, United States
Borgess Medical Center
🇺🇸
Kalamazoo, Michigan, United States
West Michigan Cancer Center
🇺🇸
Kalamazoo, Michigan, United States
Sparrow Regional Cancer Center
🇺🇸
Lansing, Michigan, United States
William Beaumont Hospital - Royal Oak Campus
🇺🇸
Royal Oak, Michigan, United States
St. Mary Mercy Hospital
🇺🇸
Livonia, Michigan, United States
St. Joseph Mercy Oakland
🇺🇸
Pontiac, Michigan, United States
Mercy Regional Cancer Center at Mercy Hospital
🇺🇸
Port Huron, Michigan, United States
Seton Cancer Institute at Saint Mary's - Saginaw
🇺🇸
Saginaw, Michigan, United States
Lakeland Regional Cancer Care Center - St. Joseph
🇺🇸
Saint Joseph, Michigan, United States
MeritCare Bemidji
🇺🇸
Bemidji, Minnesota, United States
St. John Macomb Hospital
🇺🇸
Warren, Michigan, United States
Mercy and Unity Cancer Center at Mercy Hospital
🇺🇸
Coon Rapids, Minnesota, United States
Fairview Ridges Hospital
🇺🇸
Burnsville, Minnesota, United States
Humphrey Cancer Center at North Memorial Outpatient Center
🇺🇸
Robbinsdale, Minnesota, United States
Willmar Cancer Center at Rice Memorial Hospital
🇺🇸
Willmar, Minnesota, United States
Regional Cancer Center at Singing River Hospital
🇺🇸
Pascagoula, Mississippi, United States
Cancer Institute of Cape Girardeau, LLC
🇺🇸
Cape Girardeau, Missouri, United States
CCOP - Montana Cancer Consortium
🇺🇸
Billings, Montana, United States
Bozeman Deaconess Cancer Center
🇺🇸
Bozeman, Montana, United States
Billings Clinic - Downtown
🇺🇸
Billings, Montana, United States
Cancer Resource Center - Lincoln
🇺🇸
Lincoln, Nebraska, United States
Sletten Cancer Institute at Benefis Healthcare
🇺🇸
Great Falls, Montana, United States
Nebraska Medical Center
🇺🇸
Omaha, Nebraska, United States
Memorial Sloan-Kettering Cancer Center - Basking Ridge
🇺🇸
Basking Ridge, New Jersey, United States
Center for Cancer Care at Exeter Hospital
🇺🇸
Exeter, New Hampshire, United States
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
🇺🇸
Lebanon, New Hampshire, United States
Kingsbury Center for Cancer Care at Cheshire Medical Center
🇺🇸
Keene, New Hampshire, United States
AtlantiCare Cancer Care Institute at AtlantiCare Regional Medical Center - Mainland Campus
🇺🇸
Galloway, New Jersey, United States
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
🇺🇸
New Brunswick, New Jersey, United States
Capital Health Regional Cancer Center
🇺🇸
Pennington, New Jersey, United States
Saint Peter's University Hospital
🇺🇸
New Brunswick, New Jersey, United States
Cancer Institute of New Jersey at Cooper - Voorhees
🇺🇸
Voorhees, New Jersey, United States
Fox Chase Virtua Health Cancer Program at Virtua West Jersey
🇺🇸
Voorhees, New Jersey, United States
Roswell Park Cancer Institute
🇺🇸
Buffalo, New York, United States
Stich Radiation Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
🇺🇸
New York, New York, United States
Hudson Valley Oncology Associates
🇺🇸
Poughkeepsie, New York, United States
St. Luke's - Roosevelt Hospital Center - St.Luke's Division
🇺🇸
New York, New York, United States
Dyson Center for Cancer Care at Vassar Brothers Medical Center
🇺🇸
Poughkeepsie, New York, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center
🇺🇸
Rochester, New York, United States
Memorial Sloan-Kettering Cancer Center - Rockville Centre
🇺🇸
Rockville Centre, New York, United States
Mission Hospitals - Memorial Campus
🇺🇸
Asheville, North Carolina, United States
Randolph Hospital
🇺🇸
Asheboro, North Carolina, United States
Blumenthal Cancer Center at Carolinas Medical Center
🇺🇸
Charlotte, North Carolina, United States
Coleman Radiation Oncology Center at Carter General Hospital
🇺🇸
Morehead City, North Carolina, United States
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
🇺🇸
Pinehurst, North Carolina, United States
CCOP - MeritCare Hospital
🇺🇸
Fargo, North Dakota, United States
MeritCare Broadway
🇺🇸
Fargo, North Dakota, United States
Summa Center for Cancer Care at Akron City Hospital
🇺🇸
Akron, Ohio, United States
Roger Maris Cancer Center at MeritCare Hospital
🇺🇸
Fargo, North Dakota, United States
Adena Regional Medical Center
🇺🇸
Chillicothe, Ohio, United States
Riverside Methodist Hospital Cancer Care
🇺🇸
Columbus, Ohio, United States
Hematology Oncology Center
🇺🇸
Elyria, Ohio, United States
Grady Memorial Hospital
🇺🇸
Delaware, Ohio, United States
Lima Memorial Hospital
🇺🇸
Lima, Ohio, United States
Community Cancer Center
🇺🇸
Elyria, Ohio, United States
Cleveland Clinic Cancer Center
🇺🇸
Independence, Ohio, United States
Strecker Cancer Center at Marietta Memorial Hospital
🇺🇸
Marietta, Ohio, United States
Hillcrest Cancer Center at Hillcrest Hospital
🇺🇸
Mayfield Heights, Ohio, United States
Lake/University Ireland Cancer Center
🇺🇸
Mentor, Ohio, United States
Northwest Ohio Oncology Center
🇺🇸
Maumee, Ohio, United States
Southwest General Health Center
🇺🇸
Middleburg Heights, Ohio, United States
Licking Memorial Cancer Care Program at Licking Memorial Hospital
🇺🇸
Newark, Ohio, United States
UHHS Chagrin Highlands Medical Center
🇺🇸
Orange Village, Ohio, United States
Parma Community General Hospital
🇺🇸
Parma, Ohio, United States
Cancer Care Center, Incorporated
🇺🇸
Salem, Ohio, United States
Southern Ohio Medical Center Cancer Center
🇺🇸
Portsmouth, Ohio, United States
St. Charles Mercy Hospital
🇺🇸
Oregon, Ohio, United States
Community Hospital of Springfield and Clark County
🇺🇸
Springfield, Ohio, United States
Tony Teramana Cancer Center
🇺🇸
Steubenville, Ohio, United States
Flower Hospital Cancer Center
🇺🇸
Sylvania, Ohio, United States
Toledo Hospital
🇺🇸
Toledo, Ohio, United States
St. Anne Mercy Hospital
🇺🇸
Toledo, Ohio, United States
St. Vincent Mercy Medical Center
🇺🇸
Toledo, Ohio, United States
CCOP - Toledo Community Hospital
🇺🇸
Toledo, Ohio, United States
Toledo Clinic, Incorporated - Main Clinic
🇺🇸
Toledo, Ohio, United States
Mount Carmel St. Ann's Cancer Center
🇺🇸
Westerville, Ohio, United States
UHHS Westlake Medical Center
🇺🇸
Westlake, Ohio, United States
Cancer Treatment Center
🇺🇸
Wooster, Ohio, United States
Genesis - Good Samaritan Hospital
🇺🇸
Zanesville, Ohio, United States
Cleveland Clinic - Wooster
🇺🇸
Wooster, Ohio, United States
Natalie Warren Bryant Cancer Center at St. Francis Hospital
🇺🇸
Tulsa, Oklahoma, United States
Willamette Valley Cancer Center - Eugene
🇺🇸
Eugene, Oregon, United States
Three Rivers Community Hospital
🇺🇸
Grants Pass, Oregon, United States
Geisinger Cancer Institute at Geisinger Health
🇺🇸
Danville, Pennsylvania, United States
UPMC Cancer Center at Jefferson Regional Medical Center
🇺🇸
Clairton, Pennsylvania, United States
UPMC Cancer Center at Beaver Medical Center
🇺🇸
Beaver, Pennsylvania, United States
Adams Cancer Center
🇺🇸
Gettysburg, Pennsylvania, United States
Lancaster General Hospital
🇺🇸
Lancaster, Pennsylvania, United States
UPMC Cancer Center at UPMC McKeesport
🇺🇸
McKeesport, Pennsylvania, United States
Upper Delaware Valley Cancer Center
🇺🇸
Milford, Pennsylvania, United States
Jameson Memorial Hospital - North Campus
🇺🇸
New Castle, Pennsylvania, United States
Fox Chase Cancer Center - Philadelphia
🇺🇸
Philadelphia, Pennsylvania, United States
Cancer Center of Paoli Memorial Hospital
🇺🇸
Paoli, Pennsylvania, United States
Albert Einstein Cancer Center
🇺🇸
Philadelphia, Pennsylvania, United States
St. Joseph Medical Center
🇺🇸
Reading, Pennsylvania, United States
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
🇺🇸
Reading, Pennsylvania, United States
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
🇺🇸
Wilkes-Barre, Pennsylvania, United States
Lankenau Cancer Center at Lankenau Hospital
🇺🇸
Wynnewood, Pennsylvania, United States
York Cancer Center at Apple Hill Medical Center
🇺🇸
York, Pennsylvania, United States
AnMed Cancer Center
🇺🇸
Anderson, South Carolina, United States
Cancer Centers of the Carolinas - Grove Commons
🇺🇸
Greenville, South Carolina, United States
Hilton Head Radiation Oncology Center
🇺🇸
Hilton Head Island, South Carolina, United States
CCOP - Upstate Carolina
🇺🇸
Spartanburg, South Carolina, United States
Rapid City Regional Hospital
🇺🇸
Rapid City, South Dakota, United States
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
🇺🇸
Spartanburg, South Carolina, United States
Texas Oncology, PA at Texas Cancer Center - Denton South
🇺🇸
Denton, Texas, United States
Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital
🇺🇸
Fort Worth, Texas, United States
Texas Oncology, PA at Harris Center HEB
🇺🇸
Bedford, Texas, United States
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
🇺🇸
Dallas, Texas, United States
Longview Cancer Center
🇺🇸
Longview, Texas, United States
Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
🇺🇸
Sugar Land, Texas, United States
Sandra L. Maxwell Cancer Center
🇺🇸
Cedar City, Utah, United States
Texas Oncology, PA - Wichita Falls
🇺🇸
Wichita Falls, Texas, United States
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
🇺🇸
Murray, Utah, United States
Logan Regional Hospital
🇺🇸
Logan, Utah, United States
Utah Valley Regional Medical Center - Provo
🇺🇸
Provo, Utah, United States
Fletcher Allen Health Care - University Health Center Campus
🇺🇸
Burlington, Vermont, United States
INOVA Alexandria Hospital
🇺🇸
Alexandria, Virginia, United States
St. Joseph Cancer Center
🇺🇸
Bellingham, Washington, United States
Virginia Mason Medical Center
🇺🇸
Seattle, Washington, United States
Martha Jefferson Hospital Cancer Care Center
🇺🇸
Charlottesville, Virginia, United States
Danville Regional Medical Center
🇺🇸
Danville, Virginia, United States
St. Francis Hospital
🇺🇸
Federal Way, Washington, United States
Coastal Cancer Center at Sentara Virginia Beach General Hospital
🇺🇸
Virginia Beach, Virginia, United States
Good Samaritan Cancer Center
🇺🇸
Puyallup, Washington, United States
Franciscan Cancer Center at St. Joseph Medical Center
🇺🇸
Tacoma, Washington, United States
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
🇺🇸
Yakima, Washington, United States
Cancer Care Northwest - Spokane South
🇺🇸
Spokane, Washington, United States
Legacy Salmon Creek Medical Center
🇺🇸
Vancouver, Washington, United States
MultiCare Regional Cancer Center at Tacoma General Hospital
🇺🇸
Tacoma, Washington, United States
West Virginia University Health Sciences Center - Charleston
🇺🇸
Charleston, West Virginia, United States
Fox Valley Hematology and Oncology - East Grant Street
🇺🇸
Appleton, Wisconsin, United States
Theda Care Cancer Institute
🇺🇸
Appleton, Wisconsin, United States
Columbia-Saint Mary's Water Tower Medical Commons
🇺🇸
Milwaukee, Wisconsin, United States
Gundersen Lutheran Center for Cancer and Blood
🇺🇸
La Crosse, Wisconsin, United States
Central Wisconsin Cancer Program at Agnesian HealthCare
🇺🇸
Fond Du Lac, Wisconsin, United States
Community Memorial Hospital Cancer Care Center
🇺🇸
Menomonee Falls, Wisconsin, United States
All Saints Cancer Center at Wheaton Franciscan Healthcare
🇺🇸
Racine, Wisconsin, United States
University of Wisconcin Cancer Center at Aspirus Wausau Hospital
🇺🇸
Wausau, Wisconsin, United States
London Regional Cancer Program at London Health Sciences Centre
🇨🇦
London, Ontario, Canada
D.N. Greenwald Center
🇺🇸
Mukwonago, Wisconsin, United States
West Allis Memorial Hospital
🇺🇸
West Allis, Wisconsin, United States
Regional Cancer Center at Oconomowoc Memorial Hospital
🇺🇸
Oconomowoc, Wisconsin, United States
Doctor H. Bliss Murphy Cancer Centre
🇨🇦
Saint John's, Newfoundland and Labrador, Canada
Centre Hospitalier Universitaire de Quebec
🇨🇦
Quebec City, Quebec, Canada
Saskatoon Cancer Centre at the University of Saskatchewan
🇨🇦
Saskatoon, Saskatchewan, Canada
Norton Suburban Hospital
🇺🇸
Louisville, Kentucky, United States
Florida Hospital Cancer Institute at Florida Hospital Orlando
🇺🇸
Orlando, Florida, United States
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
🇺🇸
Hershey, Pennsylvania, United States
Saint Elizabeth Cancer Institute at Saint Elizabeth Regional Medical Center
🇺🇸
Lincoln, Nebraska, United States
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
🇺🇸
Chapel Hill, North Carolina, United States
Hollings Cancer Center at Medical University of South Carolina
🇺🇸
Charleston, South Carolina, United States
University of Florida Shands Cancer Center
🇺🇸
Gainesville, Florida, United States
Cancer Research Center of Hawaii
🇺🇸
Honolulu, Hawaii, United States
Queen's Cancer Institute at Queen's Medical Center
🇺🇸
Honolulu, Hawaii, United States
Straub Clinic and Hospital, Incorporated
🇺🇸
Honolulu, Hawaii, United States
Hawaii Medical Center - East
🇺🇸
Honolulu, Hawaii, United States
CCOP - Iowa Oncology Research Association
🇺🇸
Des Moines, Iowa, United States
John Stoddard Cancer Center at Iowa Methodist Medical Center
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates at Mercy Cancer Center
🇺🇸
Des Moines, Iowa, United States
Mercy Cancer Center at Mercy Medical Center - Des Moines
🇺🇸
Des Moines, Iowa, United States
John Stoddard Cancer Center at Iowa Lutheran Hospital
🇺🇸
Des Moines, Iowa, United States
Lucille P. Markey Cancer Center at University of Kentucky
🇺🇸
Lexington, Kentucky, United States
MBCCOP - LSU Health Sciences Center
🇺🇸
New Orleans, Louisiana, United States
Medical Center of Louisiana - New Orleans
🇺🇸
New Orleans, Louisiana, United States
CCOP - Ochsner
🇺🇸
New Orleans, Louisiana, United States
New Mexico Cancer Center
🇺🇸
Albuquerque, New Mexico, United States
University of New Mexico Cancer Center
🇺🇸
Albuquerque, New Mexico, United States
Veterans Affairs Medical Center - Richmond
🇺🇸
Richmond, Virginia, United States
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
🇺🇸
Madison, Wisconsin, United States
Cross Cancer Institute at University of Alberta
🇨🇦
Edmonton, Alberta, Canada
Highland Hospital of Rochester
🇺🇸
Rochester, New York, United States
St. Joseph Hospital Regional Cancer Center - Orange
🇺🇸
Orange, California, United States
Fairview Southdale Hospital
🇺🇸
Edina, Minnesota, United States
Margaret and Charles Juravinski Cancer Centre
🇨🇦
Hamilton, Ontario, Canada
Foote Memorial Hospital
🇺🇸
Jackson, Michigan, United States
Cancer Center of Kansas, PA - El Dorado
🇺🇸
El Dorado, Kansas, United States
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
🇺🇸
Vineland, New Jersey, United States
Northeast Radiation Oncology Center
🇺🇸
Dunmore, Pennsylvania, United States
Texas Oncology, PA at Texas Cancer Center - Sherman
🇺🇸
Sherman, Texas, United States
Barnes-Jewish West County Hospital
🇺🇸
Saint Louis, Missouri, United States